Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$30.69
+5.23%
Mkt Cap $3.13B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $11.67M | $114.11M | +877.88% | -$1.13 | -$0.10 | +91.15% | — | — |
| Q4 2025 Nov 4, 2025 | $13.22M | $9.70M | -26.61% | -$0.98 | -$1.10 | -12.24% | — | — |
| Q3 2025 Aug 5, 2025 | $11.54M | $8.47M | -26.62% | -$1.04 | -$1.00 | +3.85% | — | — |
| Q2 2025 May 6, 2025 | $15.52M | $7.47M | -51.86% | -$1.11 | -$1.24 | -11.71% | — | — |
| Q1 2025 Feb 25, 2025 | $16.47M | $30.07M | +82.51% | -$1.25 | -$1.09 | +12.80% | — | — |
| Q4 2024 Nov 5, 2024 | $15.12M | $14.27M | -5.64% | -$1.13 | -$1.17 | -3.54% | — | — |
| Q3 2024 Aug 6, 2024 | $13.73M | $11.77M | -14.26% | -$1.13 | -$1.11 | +1.77% | — | — |
| Q2 2024 May 7, 2024 | $16.97M | $7.41M | -56.33% | -$1.45 | -$1.21 | +16.55% | — | — |
| Q1 2024 Feb 27, 2024 | $18.67M | $316.19M | +1593.58% | -$1.01 | $1.73 | +271.29% | — | — |
| Q4 2023 Nov 8, 2023 | $19.91M | $17.19M | -13.65% | -$1.37 | -$1.22 | +10.95% | — | — |
| Q3 2023 Aug 8, 2023 | $18.05M | $20.12M | +11.45% | -$1.38 | -$1.08 | +21.74% | — | — |
| Q2 2023 May 10, 2023 | $14.08M | $24.21M | +71.93% | -$1.36 | -$1.33 | +2.21% | — | — |
| Q1 2023 Feb 28, 2023 | $12.71M | $20.04M | +57.61% | -$1.32 | -$0.54 | +59.09% | — | — |
| Q4 2022 Nov 7, 2022 | $7.15M | $15.80M | +120.95% | -$1.30 | -$1.56 | -20.00% | — | — |
| Q3 2022 Aug 9, 2022 | $8.39M | $16.65M | +98.48% | -$1.08 | -$1.02 | +5.56% | — | — |
| Q2 2022 May 9, 2022 | $44.14M | $8.43M | -80.90% | -$1.10 | -$1.01 | +8.18% | — | — |
| Q1 2022 Feb 28, 2022 | $8.56M | $51.07M | +496.37% | -$1.02 | -$0.85 | +16.67% | — | — |
| Q4 2021 Nov 8, 2021 | $1.13M | $763.00K | -32.48% | -$0.78 | -$0.42 | +46.15% | — | — |
| Q3 2021 Aug 10, 2021 | $5.38K | $6.00K | +11.63% | -$0.58 | -$0.95 | -63.79% | — | — |
| Q2 2021 May 11, 2021 | $13.64K | $6.00K | -56.03% | -$0.72 | -$3.35 | -365.28% | — | — |